Insider trade

CEO sold ~$954K of GILD shares in the open market

Traded Oct 28, 2025 · Filed Oct 29, 2025

Gilead SciencesGILD

~$954K
Reported value · 7,978 sh @ $119.5371: 583K
Holds after · shares reported: +25.1%
stock since the trade · S&P 500 +11.2%, $117.88 → $147.50 on Oct 1

Why it stands out

The boss of Gilead Sciences sold $954K of Gilead Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 28, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 29, 2025

CEO$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$953,667

Shares × reported transaction price

Timing vs results

82 days after results of Aug 7, 2025, 2 days before results of Oct 30, 2025

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $117.88 on Oct 28, 2025, 34% above its 52-week low and 5% below its high, after a 6% rise over the previous 30 trading days

52-week range $87.75 (Nov 19, 2024) to $124.08 (Oct 21, 2025), 83% of the way up, from 250 adjusted closes. 30 trading days earlier: $110.86 on Sep 16, 2025. Describes the past only, not a forecast

Layoff notice nearby

A WARN layoff notice covering 17 workers was filed in California on November 12, 2025.

From the official state WARN list, 15 days after the trade. Shown for timing only; the two filings are separate

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+4.2%	-1.4%	+5.6%
30 days	+5.0%	+0.1%	+4.9%
90 days	+18.0%	+2.3%	+15.7%
180 days	+9.1%	+4.7%	+4.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0001638643-25-000011
Filed / recorded: Oct 29, 2025, 8:14 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: GILEAD SCIENCES, INC.
Issuer CIK: 882095
Ticker: GILD
Reporting person: Daniel Patrick O'day
Relationship: Director, Officer
Officer title: Chairman & CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Oct 28, 2025
Transaction code: S
Shares / units: 7,978
Price per share: $119.5371
Acquired / disposed: Disposed (D)
Shares owned after: 583,225
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
Sale prices for the transactions reported range from $119.08 to $120.06. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.